vs
Chord Energy Corp（CHRD）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Chord Energy Corp的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 7.2%，领先27.2%），Royalty Pharma plc同比增速更快（4.8% vs -19.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 3.8%）
Chord Energy Corp（前身为绿洲石油）是一家从事油气勘探、水力压裂业务的能源企业，核心运营区域位于美国北达科他州与蒙大拿州的威利斯顿盆地，注册地为特拉华州，总部设在得克萨斯州休斯敦，在北达科他州威利斯顿设有办事处。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CHRD vs RPRX — 直观对比
营收规模更大
CHRD
是对方的1.9倍
$622.0M
营收增速更快
RPRX
高出24.4%
-19.6%
净利率更高
RPRX
高出27.2%
7.2%
两年增速更快
RPRX
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $84.4M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 7.9% | 62.4% |
| 净利率 | 7.2% | 34.4% |
| 营收同比 | -19.6% | 4.8% |
| 净利润同比 | -59.9% | 2.9% |
| 每股收益（稀释后） | $1.59 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHRDRPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.3B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.5B | $593.6M | ||
| Q3 24 | $1.5B | $564.7M | ||
| Q2 24 | $1.3B | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润CHRDRPRX
| Q4 25 | $84.4M | $214.2M | ||
| Q3 25 | $130.1M | $288.2M | ||
| Q2 25 | $-389.9M | $30.2M | ||
| Q1 25 | $219.8M | $238.3M | ||
| Q4 24 | $210.6M | $208.2M | ||
| Q3 24 | $225.3M | $544.0M | ||
| Q2 24 | $213.4M | $102.0M | ||
| Q1 24 | $199.4M | $4.8M |
毛利率CHRDRPRX
| Q4 25 | — | — | ||
| Q3 25 | 74.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 77.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CHRDRPRX
| Q4 25 | 7.9% | 62.4% | ||
| Q3 25 | 13.0% | 70.1% | ||
| Q2 25 | -34.2% | 36.3% | ||
| Q1 25 | 27.8% | 94.0% | ||
| Q4 24 | 18.2% | 60.9% | ||
| Q3 24 | 18.8% | — | ||
| Q2 24 | 22.9% | 50.2% | ||
| Q1 24 | 25.1% | -13.0% |
净利率CHRDRPRX
| Q4 25 | 7.2% | 34.4% | ||
| Q3 25 | 9.9% | 47.3% | ||
| Q2 25 | -33.0% | 5.2% | ||
| Q1 25 | 18.1% | 41.9% | ||
| Q4 24 | 14.5% | 35.1% | ||
| Q3 24 | 15.5% | 96.3% | ||
| Q2 24 | 16.9% | 19.0% | ||
| Q1 24 | 18.4% | 0.8% |
每股收益（稀释后）CHRDRPRX
| Q4 25 | $1.59 | $0.49 | ||
| Q3 25 | $2.26 | $0.67 | ||
| Q2 25 | $-6.77 | $0.07 | ||
| Q1 25 | $3.66 | $0.55 | ||
| Q4 24 | $3.53 | $0.46 | ||
| Q3 24 | $3.59 | $1.21 | ||
| Q2 24 | $4.25 | $0.23 | ||
| Q1 24 | $4.65 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.5M | $618.7M |
| 总债务越低越好 | $1.5B | $9.0B |
| 股东权益账面价值 | $8.1B | $9.7B |
| 总资产 | $13.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.18× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CHRDRPRX
| Q4 25 | $189.5M | $618.7M | ||
| Q3 25 | $629.2M | $938.9M | ||
| Q2 25 | $40.5M | $631.9M | ||
| Q1 25 | $35.8M | $1.1B | ||
| Q4 24 | $37.0M | $929.0M | ||
| Q3 24 | $52.0M | $950.1M | ||
| Q2 24 | $197.4M | $1.8B | ||
| Q1 24 | $296.4M | $843.0M |
总债务CHRDRPRX
| Q4 25 | $1.5B | $9.0B | ||
| Q3 25 | $1.5B | $8.9B | ||
| Q2 25 | $918.9M | $8.0B | ||
| Q1 25 | $798.8M | $7.6B | ||
| Q4 24 | $842.6M | $7.6B | ||
| Q3 24 | $867.2M | $7.6B | ||
| Q2 24 | $1.0B | $7.6B | ||
| Q1 24 | $396.3M | $6.1B |
股东权益CHRDRPRX
| Q4 25 | $8.1B | $9.7B | ||
| Q3 25 | $8.1B | $9.6B | ||
| Q2 25 | $8.1B | $9.5B | ||
| Q1 25 | $8.6B | $9.8B | ||
| Q4 24 | $8.7B | $10.3B | ||
| Q3 24 | $8.8B | $10.3B | ||
| Q2 24 | $8.8B | $9.8B | ||
| Q1 24 | $5.1B | $9.9B |
总资产CHRDRPRX
| Q4 25 | $13.1B | $19.6B | ||
| Q3 25 | $13.1B | $19.3B | ||
| Q2 25 | $12.5B | $18.3B | ||
| Q1 25 | $13.1B | $17.6B | ||
| Q4 24 | $13.0B | $18.2B | ||
| Q3 24 | $13.0B | $18.0B | ||
| Q2 24 | $13.1B | $17.7B | ||
| Q1 24 | $7.0B | $16.1B |
负债/权益比CHRDRPRX
| Q4 25 | 0.18× | 0.92× | ||
| Q3 25 | 0.18× | 0.93× | ||
| Q2 25 | 0.11× | 0.84× | ||
| Q1 25 | 0.09× | 0.78× | ||
| Q4 24 | 0.10× | 0.74× | ||
| Q3 24 | 0.10× | 0.74× | ||
| Q2 24 | 0.12× | 0.78× | ||
| Q1 24 | 0.08× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $405.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 4.80× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CHRDRPRX
| Q4 25 | $405.0M | $827.1M | ||
| Q3 25 | $559.0M | $702.6M | ||
| Q2 25 | $419.8M | $364.0M | ||
| Q1 25 | $656.9M | $596.1M | ||
| Q4 24 | $566.5M | $742.5M | ||
| Q3 24 | $663.2M | $703.6M | ||
| Q2 24 | $460.9M | $658.2M | ||
| Q1 24 | $406.7M | $664.6M |
现金转化率CHRDRPRX
| Q4 25 | 4.80× | 3.86× | ||
| Q3 25 | 4.30× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 2.99× | 2.50× | ||
| Q4 24 | 2.69× | 3.57× | ||
| Q3 24 | 2.94× | 1.29× | ||
| Q2 24 | 2.16× | 6.45× | ||
| Q1 24 | 2.04× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHRD
| Oil Production | $801.0M | 68% |
| Purchased Oil Sales | $285.8M | 24% |
| Natural Gas And Natural Gas Liquid Services | $75.6M | 6% |
| Purchased Gas Sales | $7.0M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
